bioinformatics tool News
-
INCOGEN Completes NIH Funded BISTI Project
INCOGEN and its collaborators announced the completion of the five-year long clear cell renal cell carcinoma (ccRCC) project. This multidisciplinary project was funded by several National Cancer Institute Small Business Innovation Research (SBIR) grants and involved collaborations with the Mayo Clinic, Eastern Virginia Medical School, and Johns Hopkins University. It resulted in the development ...
-
AlveoliX and EpiEndo Receive Eurostar Grant
The Swiss National Science Foundation SNSF and the Swiss Innovation Agency Innosuisse have granted a BRIDGE Discovery project to the Laboratory of Microbiology at the University of Neuchâtel (LAMUN) in cooperation with the Centre Hospitalier Universitaire Vaudois (CHUV), the Swiss Institute of Bioinformatics (SIB), and two innovative Swiss startups AlveoliX AG and SiMPLInext SA. The aim of ...
By AlveoliX AG
-
AlveoliX part of a new BRIDGE Discovery project
We are thrilled to be part of the new BRIDGE Discovery project granted by the SNSF Swiss National Science Foundation and Innosuisse to the Laboratory of Microbiology at the Université de Neuchâtel (LAMUN) in cooperation with the CHUV / Centre hospitalier universitaire vaudois, the SIB Swiss Institute of Bioinformatics, ...
By AlveoliX AG
-
SeqOne expands its commercial presence in Middle Eastern markets
SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in Middle Eastern markets. Under the terms of this agreement, Global Diagnostic Solutions Ltd. will be responsible for the Business Development, ...
-
Creative Proteomics Enhances Proteomics Research with Advanced Post-Translational Modification Analysis Services
Creative Proteomics, a leading provider of advanced proteomics services globally, has recently extended its services portfolio with protein post-translational modification (PTM) analysis. This new addition will provide valuable insights into the dynamic aspect of proteins, their regulation, and the fine-tuning of their functions. Proteins, while being the workhorse of cellular function, undergo ...
-
Appointment boosts CSIRO bioinformatics research
“Bioinformatics, the interface between computing and biology, is a fast growing field and Dr Jermiin’s appointment is part of CSIRO’s move to build its skills base in genome bioinformatics,” CSIRO Entomology’s Chief, Dr Mark Lonsdale said. “Given Dr Jermiin’s experience and research excellence, we are excited about what he brings to our research in genome bioinformatics.” Dr Jermiin’s ...
-
Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. The platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and ...
By CD Genomics
-
CD Genomics Introduces Advanced Exosomal RNA Sequencing Service for Enhanced Molecular Insights
CD Genomics, a leading provider of transcriptomics sequencing solutions, is pleased to announce the launch of its Exosomal RNA Sequencing service. This innovative service is set to provide researchers with comprehensive and accurate analysis of exosomal RNA, facilitating a deeper understanding of their functional significance in various biological processes. Exosomes, small extracellular ...
By CD Genomics
-
Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service
MicrobioSeq is the microbial genomics division on behalf of CD Genomics, headquartered in New York, USA. The product manager is pleased to announce the launch of its Microbial Biomarker Discovery service, a revolutionary solution that promises to transform microbiology research. Microbiome research has rapidly gained momentum in recent years as scientists have come to appreciate the vital role ...
By CD Genomics
-
Creative Proteomics Upgraded Exosome Proteomics Service to Accelerate Biomarker Discovery Research
Creative Proteomics, an integrated CRO company committed to providing a full range of services to support various proteome-related research projects from identification of single proteins to large-scale proteomic studies, has recently upgraded its fully-developed Exosome Proteomics Service to identify and quantify the proteins in exosomes. The company can also help discover biomarkers after ...
-
CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service
CD Genomics, a trailblazing genomics and bioinformatics services provider, is delighted to announce the launch of the Long Amplicon Analysis (LAA) service, a mature genomic research method that promises to revolutionize the field. With LAA, scientists can now explore intricate genomic landscapes, facilitating groundbreaking discoveries and advancements in various branches of genomics. Long ...
By CD Genomics
-
Revolutionizing Metabolomics: Creative Proteomics Unveils LC-MS/MS Untargeted Metabolomics Service
Creative Proteomics, a trailblazer in advanced proteomics and metabolomics services, is proud to unveil its groundbreaking LC-MS/MS Untargeted Metabolomics service. This release marks a pivotal moment in the world of metabolomics research, offering scientists a game-changing tool to explore the hidden complexities of the metabolome. Metabolomics, the systematic study of small molecules within ...
-
Creative Proteomics Enhances Your Project with Cell Surface Proteomics Service
Creative Proteomics is an integrated CRO company committed to providing a full range of services in order to support various proteomic research projects, ranging from the identification of single proteins to large-scale proteomic studies. Based on its biotin affinity purification technology, the company has upgraded the cell surface protein purification and enrichment protocols to enable ...
-
MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research
MicrobioSeq is the microbial genomics division on behalf of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a renowned reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. The product manager is pleased to announce the launch of the Plasmid Identification service, thus helping researchers to efficiently ...
By CD Genomics
-
Agilent Technologies and national university of singapore sign research collaboration agreement for lipidomics research
Agilent Technologies Inc. (NYSE: A) and the National University of Singapore (NUS) today announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states. Under the terms of the agreement, Agilent's provision of sophisticated test and ...
-
Microbiotica raises £50 million ($67 million) to advance pipeline of microbiome-based therapeutics
Microbiotica, a leading player in discovering and developing microbiome-based therapeutics and biomarkers, today announced the completion of a £50 million ($67 million) Series B financing round – the largest microbiome-related financing in Europe to date. The international investment syndicate was co-led by Flerie Invest, a major Swedish life science investor focussing on companies ...
-
SeqOne wins prestigious iLab grant to improve genomics analysis software in healthcare
SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology. i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking start-ups. The award is associated with a grant aimed at helping each ...
-
Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology
Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces that MB097 is now in pre-clinical development for treatment of patients not responding to anti-PD1 therapy. Clinical trials are due to begin in 2022. MB097 is clinically designed and experimentally validated. Studies have shown that the gut microbiome plays a critical and causative role in determining ...
-
Microbiotica`s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology
MB097 is a consortium of bacteria at the core of the microbiome signature predictive of patient response to Immune Checkpoint Inhibitor therapy Data show potent anti-tumour efficacy in vivo and in vitro MB097 is in manufacturing process development for Ph1b study expected to start next year MB097 is the first microbiome precision medicine in immuno-oncology, clinically designed in the same ...
-
CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis
CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as providing access to the latest software, technologies, and expertise with competitive prices and fast turnarounds for researchers. The company has announced the introduction of the PyMOL software, a powerful utility for studying proteins, DNA, and other ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you